| |
| |
SPOT ON
|
| |
Drug companies: who belongs to whom?
|
| |
| |
THERAPIES FROM A CRITICAL VIEWPOINT
|
| |
Breast cancer: the value of systemic adjuvant therapy
Vitamin D (e.g. VIGANTOLETTEN) and calcium for osteoporosis in the elderly
|
| |
| |
BEWARE MISINFORMATION
|
| |
Levodopa-benserazid combination RESTEX: according to SPC now with fewer side effects?
|
| |
| |
a-t READERS' QUESTIONS AND COMMENTS
|
| |
Animadversion on antidepressants: what to do? |
 |
Bevacizumab (AVASTIN): inhibitior of angiogenesis for colorectal cancer
|
| |
| |
IN BRIEF
|
| |
Radical prostatectomy reduces mortality in early prostate cancer
Cox-2-inhibitor parecoxib (DYNASTAT) off the market in Switzerland
|
| |
| |
CURRENT ADR NETWORK REPORT
|
| |
Skin necrosis after injection of glatiramer acetate (COPAXONE)
|
| |
| |
SIDE EFFECTS
|
| |
Bisphosphonates: non-traumatic fractures with protracted healing with alendronat (FOSAMAX)
Exophtalmos with glitazones
|
| |